Stock Price
260.00
Daily Change
13.30 5.39%
Monthly
10.26%
Yearly
-35.56%
Q2 Forecast
247.42

Novo Nordisk reported DKK37.3B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Bausch Health Companies USD 986M 74M Sep/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
Merck USD 8.39B 1.97B Sep/2025
Novartis USD 4.77B 1.11B Dec/2025
Novo Nordisk DKK 37.3B 5.86B Dec/2025
Novo Nordisk DKK 31.44B 6.84B Sep/2025
Pacira USD 38.71M 10.65M Dec/2025
Sanofi EUR 3.31B 3.65B Mar/2026
Supernus Pharmaceuticals USD 48.5M 6.6M Dec/2025